The latest new contracts, like Crescita Therapeutics’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Crescita Signs Exclusive Distribution Agreement with NanoPass Technologies Ltd. for MicronJetTM600
Crescita Therapeutics Inc. announced the signing of an exclusive distribution agreement with NanoPass Technologies Ltd. to launch and distribute MicronJetTM600 in the Canadian medical aesthetics market. MicronJet is an innovative intradermal injection device that offers precise and comfortable injection, enhancing Crescita's medical aesthetic portfolio.
Company Information
Company
Crescita Therapeutics
Location
Laval, Quebec, Canada
About
Crescita Therapeutics Inc. is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The company offers a portfolio of high-quality, science-based non-prescription skincare products and a commercial stage prescription product. Crescita also owns multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin.
Predictive Intelligence
Strategic
ML-powered predictions for Crescita Therapeutics's next move
LavalManufacturingBiotechnologyHealth CareCosmetics